Bayer Beats Q1 EBITDA Estimates at €4.5B, Misses Sales Target

GateNews
Bayer reported adjusted EBITDA of €4.5 billion in the first quarter of 2026, exceeding analyst expectations of €3.94 billion. However, first-quarter sales reached €13.41 billion, falling short of the €13.49 billion estimate.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments